Quest Diagnostics Acquires MedXM

We represented Quest Diagnostics (NYSE: DGX) in its acquisition of Mobile Medical Examination Service (MedXM), a leading national provider of home-based health risk assessments and related services. The acquisition will expand Quest’s scale and reach in the mobile/home segment and bolster its overall capabilities in extended care. Terms of the transaction were not publicly disclosed.

Quest Diagnostics is the world’s leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions.

You Also May Be Interested In:

  • Representation of SCP Eye Care Services in its acquisition of Coastal Eye Associates, a comprehensive ophthalmology physician practice group based in Texas

    We represented SCP Eye Care Services in its acquisition of Coastal Eye Associates, a comprehensive ophthalmology physician practice group based...
    Client Type: Private Company
  • Representation of SCP Eye Care Services in its acquisition of Mitchell Refractive, a comprehensive ophthalmology and refractive surgery physician practice based in Boca Raton, Florida

    We represented SCP Eye Care Services in its acquisition of Mitchell Refractive, a comprehensive ophthalmology and refractive surgery physician practice...
    Client Type: Private Company
  • Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners

    We served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant...
    Client Type: Private Company